ArticleOpen forum infectious diseases2024

One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study.

Camilla Muccini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.